Management of Hyperglycemic Crisis with Multiple Electrolyte Derangements
Immediate Diagnosis and Risk Stratification
This patient presents with diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) complicated by severe metabolic alkalosis, hypokalemia, hypocalcemia, hypernatremia, and elevated lactate—a life-threatening constellation requiring immediate, prioritized intervention. 1
The arterial blood gas shows:
- Metabolic alkalosis (pH 7.526, expected in chronic diuretic use or vomiting) 2, 3
- Respiratory compensation (PaCO2 29 mmHg—inadequate for this degree of alkalosis, suggesting mixed disorder) 3
- Hyperglycemia (296 mg/dL) with elevated lactate (4.37 mmol/L) indicating tissue hypoperfusion 4, 1
- Severe electrolyte derangements: Sodium 160.6 mEq/L, Potassium 3.18 mEq/L, Calcium 0.87 mmol/L (ionized ~3.5 mg/dL), Chloride 119 mEq/L 4, 1, 5
Calculate effective serum osmolality: 2(160.6) + 296/18 = 337.6 mOsm/kg—consistent with HHS (>320 mOsm/kg) 4. The anion gap is 160.6 - (119 + bicarbonate) = requires bicarbonate measurement, but the alkalotic pH suggests this is NOT pure DKA 4, 1.
Critical Pre-Treatment Assessment
Before initiating any therapy, immediately obtain:
- Serum bicarbonate, beta-hydroxybutyrate, and complete metabolic panel to differentiate DKA from HHS 4, 1
- Serum magnesium level (target >0.6 mmol/L or >1.5 mg/dL)—hypomagnesemia is the most common cause of refractory hypokalemia and hypocalcemia and MUST be corrected first 6, 7
- ECG to assess for cardiac effects of hypokalemia (T-wave flattening, U waves, QT prolongation) and hypocalcemia (QT prolongation) 4, 1, 6
- Urine output verification (≥0.5 mL/kg/hour) to confirm renal function before potassium administration 1, 8
Prioritized Treatment Algorithm
Step 1: Fluid Resuscitation (First Hour)
Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour (1-1.5 L in average adult) for the first hour to restore intravascular volume and renal perfusion. 4, 1 This addresses:
- Severe hypernatremia (160.6 mEq/L)
- Hyperosmolality (337.6 mOsm/kg)
- Tissue hypoperfusion (lactate 4.37 mmol/L)
Critical caveat: In hyperosmolar patients, limit osmolality reduction to ≤3 mOsm/kg/hour to prevent cerebral edema 1. With initial osmolality of 337.6 mOsm/kg, target reduction is ≤9 mOsm/kg over first 3 hours.
Step 2: Magnesium Correction (Concurrent with Fluids)
Immediately administer IV magnesium sulfate 2-4 grams over 15-30 minutes, then 1-2 grams/hour continuous infusion until magnesium >0.6 mmol/L. 6, 7 Hypomagnesemia causes:
- Refractory hypokalemia through impaired Na-K-ATPase function 6, 7
- Hypocalcemia through impaired PTH secretion and skeletal resistance 7
- Cardiac arrhythmias independent of potassium 6, 7
Do NOT attempt potassium or calcium correction until magnesium is normalized—this is the single most common cause of treatment failure. 6, 7
Step 3: Calcium Correction (After Magnesium Initiated)
Administer calcium gluconate 10%: 10-20 mL (1-2 grams) IV over 10 minutes, then reassess ionized calcium. 1, 5 With ionized calcium of 0.87 mmol/L (~3.5 mg/dL), this represents severe hypocalcemia requiring urgent correction to prevent:
Monitor ECG continuously during calcium administration 1, 5.
Step 4: Potassium Management (CRITICAL—DO NOT START INSULIN YET)
With serum potassium of 3.18 mEq/L, insulin therapy is ABSOLUTELY CONTRAINDICATED until potassium is ≥3.3 mEq/L. 1, 8 Starting insulin now will cause life-threatening hypokalemia, cardiac arrhythmias, respiratory muscle weakness, and potential cardiac arrest 1, 8.
Immediately add 40 mEq/L potassium to IV fluids (2/3 KCl and 1/3 KPO4) and infuse at maximum safe rate until K+ ≥3.3 mEq/L. 1, 8 This typically requires:
- 20-40 mEq potassium per liter of 0.9% NaCl 1, 8
- Maximum peripheral line rate: 10 mEq/hour 1, 6
- Central line allows up to 20 mEq/hour with continuous cardiac monitoring 6
Recheck potassium every 1-2 hours during aggressive replacement. 1, 8 Despite total body potassium depletion of 3-5 mEq/kg (210-350 mEq deficit in 70 kg adult), serum levels may appear "normal" due to acidosis and insulin deficiency causing extracellular shift 1, 8.
Step 5: Insulin Therapy (ONLY After K+ ≥3.3 mEq/L)
Once potassium reaches ≥3.3 mEq/L:
Administer IV bolus of regular insulin 0.1 units/kg, followed by continuous infusion at 0.1 units/kg/hour. 1 Target glucose decline of 50-75 mg/dL/hour 1.
Continue adding 20-30 mEq/L potassium to ALL IV fluids once K+ falls below 5.5 mEq/L. 1, 8 Insulin will drive potassium intracellularly within 30-60 minutes, potentially causing dangerous hypokalemia 8.
Step 6: Addressing Metabolic Alkalosis
The metabolic alkalosis (pH 7.526) is likely contraction alkalosis from volume depletion or diuretic-induced 2, 3. Do NOT administer bicarbonate—this will worsen alkalosis. 4, 1
Treatment consists of:
- Chloride repletion through 0.9% NaCl (already initiated) 2, 3
- Potassium chloride (not potassium citrate, which worsens alkalosis) 6, 2
- Volume expansion to suppress aldosterone 2, 3
If alkalosis persists despite these measures and pH remains >7.55, consider acetazolamide 250-500 mg IV to enhance renal bicarbonate excretion 2, 3. However, this is rarely needed and should be deferred until acute crisis is stabilized.
Step 7: Transition to Maintenance Fluids (After First Hour)
After initial 1-1.5 L bolus, switch to:
- 0.45% NaCl at 250-500 mL/hour if corrected sodium remains >150 mEq/L 4, 1
- Add 20-30 mEq/L potassium (2/3 KCl, 1/3 KPO4) to each liter 1, 8
- When glucose reaches 200-250 mg/dL, switch to D5W with 0.45% NaCl to prevent hypoglycemia while continuing insulin 4, 1
Monitoring Protocol
Check the following every 2-4 hours until metabolic stabilization:
- Blood glucose (target decline 50-75 mg/dL/hour) 1
- Serum potassium, sodium, chloride, calcium, magnesium 1, 8
- Venous pH and bicarbonate 1
- Serum osmolality (target reduction ≤3 mOsm/kg/hour) 1
- Beta-hydroxybutyrate (if available—more accurate than urine ketones) 1
Continuous cardiac monitoring is mandatory given severe hypokalemia, hypocalcemia, and QT prolongation risk 1, 6, 5.
Resolution Criteria and Transition
DKA/HHS is resolved when ALL of the following are met:
Administer subcutaneous basal insulin (glargine or detemir) 2-4 hours BEFORE discontinuing IV insulin to prevent DKA recurrence. 1 This is the most common error leading to relapse 1.
Critical Pitfalls to Avoid
- Never start insulin with K+ <3.3 mEq/L—this causes life-threatening arrhythmias and cardiac arrest 1, 8
- Never supplement potassium without checking and correcting magnesium first—this is the most common cause of refractory hypokalemia 6, 7
- Never correct hypernatremia too rapidly (>10-12 mEq/L per 24 hours)—risk of cerebral edema 1
- Never give bicarbonate in metabolic alkalosis—worsens the disorder 2, 3
- Never stop IV insulin without prior subcutaneous basal insulin—causes DKA recurrence 1
- Never use potassium citrate or acetate—worsens metabolic alkalosis 6, 2
Special Considerations for This Patient
The combination of hyperglycemia + metabolic alkalosis + severe hypokalemia suggests:
- Chronic diuretic use (thiazide or loop diuretics) causing contraction alkalosis and potassium wasting 2, 3
- Vomiting causing chloride and acid loss 3
- Possible Cushing's syndrome or exogenous corticosteroids (hyperglycemia + hypokalemia + alkalosis) 4, 6
Investigate precipitating factors: infection (obtain cultures), medication non-compliance, new diabetes diagnosis, or endocrine disorder 4, 1.